Bristol Myers Squibb Adds Premier Radiopharmaceutical Platform with Acquisition of RayzeBio

Go back to Bristol Myers Squibb Adds Premier Radiopharmaceutical Platform with Acquisition of RayzeBio
Bristol-Myers Squibb (NYSE: BMY) Delayed: 66.85 -0.07 (0.1%)
Previous Close $66.92    52 Week High $77.12 
Open $66.82    52 Week Low $49.03 
Day High $67.71    P/E 43.41 
Day Low $66.78    EPS $1.54 
Volume 741,720       

(NASDAQ: RYZB) Delayed: 62.49 --0 (-0%)
Previous Close $62.49    52 Week High
Open $0.22    52 Week Low
Day High $62.49    P/E N/A 
Day Low $62.49    EPS
Volume 707